Zobrazeno 1 - 10
of 51
pro vyhledávání: '"June, Kaplow"'
Autor:
Santiago Bullich, Andre Mueller, Susan De Santi, Norman Koglin, Stephen Krause, June Kaplow, Michio Kanekiyo, Núria Roé-Vellvé, Audrey Perrotin, Aleksandar Jovalekic, David Scott, Michelle Gee, Andrew Stephens, Michael Irizarry
Publikováno v:
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-13 (2022)
Abstract Background The ability of 18F-PI-2620 PET to measure the spatial distribution of tau pathology in Alzheimer’s disease (AD) has been demonstrated in previous studies. The objective of this work was to evaluate tau deposition using 18F-PI-26
Externí odkaz:
https://doaj.org/article/8e77b5cba44a4f58a7c6388004ac5e5a
Autor:
Chad J. Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang, June Kaplow, Robert Y. K. Lai, Lars Lannfelt, Heather Bradley, Martin Rabe, Akihiko Koyama, Larisa Reyderman, Donald A. Berry, Scott Berry, Robert Gordon, Lynn D. Kramer, Jeffrey L. Cummings
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-14 (2021)
Abstract Background Lecanemab (BAN2401), an IgG1 monoclonal antibody, preferentially targets soluble aggregated amyloid beta (Aβ), with activity across oligomers, protofibrils, and insoluble fibrils. BAN2401-G000-201, a randomized double-blind clini
Externí odkaz:
https://doaj.org/article/edd30e11757844c3a76924e96d5411df
Autor:
Chad J. Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang, June Kaplow, Robert Y. K. Lai, Lars Lannfelt, Heather Bradley, Martin Rabe, Akihiko Koyama, Larisa Reyderman, Donald A. Berry, Scott Berry, Robert Gordon, Lynn D. Kramer, Jeffrey L. Cummings
Publikováno v:
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/9e3c60d518ed4e89a11178d614b7e937
Autor:
Yan Hu, Kristopher M. Kirmess, Matthew R. Meyer, Gil D. Rabinovici, Constantine Gatsonis, Barry A. Siegel, Rachel A. Whitmer, Charles Apgar, Lucy Hanna, Michio Kanekiyo, June Kaplow, Akihiko Koyama, David Verbel, Mary S. Holubasch, Stephanie S. Knapik, Jason Connor, John H. Contois, Erin N. Jackson, Scott E. Harpstrite, Randall J. Bateman, David M. Holtzman, Philip B. Verghese, Ilana Fogelman, Joel B. Braunstein, Kevin E. Yarasheski, Tim West
Publikováno v:
JAMA network open. 5(4)
The diagnostic evaluation for Alzheimer disease may be improved by a blood-based diagnostic test identifying presence of brain amyloid plaque pathology.To determine the clinical performance associated with a diagnostic algorithm incorporating plasma
Autor:
Shau Yu Lynch, Michael C Irizarry, Shobha Dhadda, David JianJun Li, Michio Kanekiyo, Tanya Bogoslovsky, Michelle Gee, Larisa Reyderman, June Kaplow, Martin Rabe, Mark Hodgkinson, Lynn D Kramer, Harald Hampel, Chad J Swanson
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Chad J Swanson, Shobha Dhadda, Michael C Irizarry, Michio Kanekiyo, David JianJun Li, June Kaplow, Robert Gordon, Helena Heanue‐Travers, Mark Hodgkinson, Lynn D Kramer
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Chad J Swanson, Michio Kanekiyo, June Kaplow, Shobha Dhadda, Michael C Irizarry, Akihiko Koyama, David JianJun Li, David Verbel, Robert Gordon, Helena Heanue‐Travers, Mark Hodgkinson, Lynn D Kramer
Publikováno v:
Alzheimer's & Dementia. 17
Publikováno v:
The journal of prevention of Alzheimer's disease. 8(2)
BACKGROUND/OBJECTIVES: Elenbecestat, an oral BACE-1 inhibitor that has been shown to reduce Aβ levels in cerebrospinal fluid, was investigated in two global phase 3 studies in early AD. Here we report on differences observed in characteristics of AP
Autor:
Scott M. Berry, Lars Lannfelt, Yong Zhang, Larisa Reyderman, Shobha Dhadda, Robert Lai, Chad J. Swanson, Jeffrey L. Cummings, Jinping Wang, Robert Gordon, Heather Bradley, Donald A. Berry, Lynn D. Kramer, June Kaplow, Akihiko Koyama, Martin Rabe
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-14 (2021)
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy
Background Lecanemab (BAN2401), an IgG1 monoclonal antibody, preferentially targets soluble aggregated amyloid beta (Aβ), with activity across oligomers, protofibrils, and insoluble fibrils. BAN2401-G000-201, a randomized double-blind clinical trial
Autor:
Jinping Wang, Chad J. Swanson, Yong Zhang, Shobha Dhadda, Robert Lai, June Kaplow, Robert Gordon, Heather Bradley, Lynn D. Kramer, Martin Rabe
Publikováno v:
Alzheimer's & Dementia. 16